Martin A. Makary, MD, nominated to be the next commissioner of the FDA, has stated that he will push to expedite reviews of new drugs for rare diseases. Makary, from Johns Hopkins University, pledged to customize the regulatory process to situations, suggesting, for example, that if a condition affects only a handful of people worldwide, two randomized control trials would not be necessary. His approach could benefit rare disease drug developers.
IXON VPN Vulnerabilities Let Attackers Gain Access to Windows & Linux Systems
A security assessment by Shelltrail revealed three critical vulnerabilities in the IXON VPN client, allowing privilege escalation on Windows and Linux. Identified as CVE-2025-ZZZ-01, CVE-2025-ZZZ-02,
%20CISO%E2%80%99s%20Core%20Focus.webp?w=0&resize=0,0&ssl=1 "Identity and Access Management (IAM)")